These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12214537)

  • 41. Use of spacer devices with inhaled steroids.
    Craig T
    Arch Intern Med; 1995 Mar; 155(5):547-8. PubMed ID: 7864715
    [No Abstract]   [Full Text] [Related]  

  • 42. Influence of two different inhalation devices on therapy compliance in asthmatic patients.
    van Schayck CP; Bijl-Hofland ID; Folgering H; Cloosterman SG; Akkermans R; van den Elshout F; van Weel C
    Scand J Prim Health Care; 2002 Jun; 20(2):126-8. PubMed ID: 12184713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Powder inhalation systems].
    Kohlhäufl M; Haidl P; Voshaar T; Häussinger K; Köhler D
    Dtsch Med Wochenschr; 2004 Sep; 129(39):2048-52. PubMed ID: 15386209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can patients use all dry powder inhalers equally well?
    Gustafsson P; Taylor A; Zanen P; Chrystyn H
    Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Understanding medication and use of drug delivery device by asthmatic in Lagos.
    Adeyeye OO; Onadeko BO
    West Afr J Med; 2008 Jul; 27(3):155-9. PubMed ID: 19256320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Adherence to therapy in bronchial asthma].
    Gillissen A; Büsch K; Juergens U
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1281-6. PubMed ID: 17541872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problems with inhaler use: a call for improved clinician and patient education.
    Fink JB; Rubin BK
    Respir Care; 2005 Oct; 50(10):1360-74; discussion 1374-5. PubMed ID: 16185371
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of inhalation technique in children in general practice: increased risk of incorrect performance with new device.
    Hagmolen of ten Have W; van de Berg NJ; Bindels PJ; van Aalderen WM; van der Palen J
    J Asthma; 2008; 45(1):67-71. PubMed ID: 18259998
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Importance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomes.
    Small M; Anderson P; Vickers A; Kay S; Fermer S
    Adv Ther; 2011 Mar; 28(3):202-12. PubMed ID: 21331556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of patient-related factors on asthma control.
    Molimard M; Le Gros V
    J Asthma; 2008 Mar; 45(2):109-13. PubMed ID: 18350401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increasing compliance with inhaled corticosteroids through the use of combination therapy.
    Holt S; Masoli M; Beasley R
    J Allergy Clin Immunol; 2004 Feb; 113(2):219-20. PubMed ID: 14767433
    [No Abstract]   [Full Text] [Related]  

  • 52. Novolizer: how does it fit into inhalation therapy?
    Magnussen H
    Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Improvement of compliance in the therapy of asthma--what about evidence and how can the effect be evaluated?].
    Petro W
    Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S394-7. PubMed ID: 19941244
    [No Abstract]   [Full Text] [Related]  

  • 54. [Inhalation therapy: techniques and use of devices--main mistakes].
    Voshaar T
    Med Klin (Munich); 2002 Dec; 97 Suppl 2():2-6. PubMed ID: 12593174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Inhaled therapy--method of choice in asthma treatment].
    Alkiewicz J
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():54-7. PubMed ID: 12518640
    [No Abstract]   [Full Text] [Related]  

  • 56. Refining the use of inhaled steroids in asthma.
    Miles J
    Hosp Med; 2000 Aug; 61(8):558-60. PubMed ID: 11045225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [After prohibition of dose aerosol inhalers with FCKW. Powder inhaler improves steroid therapy].
    MMW Fortschr Med; 2003 Mar; 145(11):61. PubMed ID: 12688205
    [No Abstract]   [Full Text] [Related]  

  • 58. Placebo inhaler devices and infection risks.
    Weller T
    Nurs Times; 2005 Oct 18-24; 101(42):50. PubMed ID: 16259203
    [No Abstract]   [Full Text] [Related]  

  • 59. Introduction: how can we improve asthma management?
    Barnes PJ
    Curr Med Res Opin; 2005; 21 Suppl 4():S1-3. PubMed ID: 16138938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determinants of patient adherence to an aerosol regimen.
    Rau JL
    Respir Care; 2005 Oct; 50(10):1346-56; discussion 1357-9. PubMed ID: 16185370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.